ARCHIVES

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

This article is from The Cancer Letter archive.

Vol. 20 No. 08 | February 25, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

University of Kansas Cancer Center Receives NCI Center Designation

July 13, 2012

The Raghavan Experiment: With $500 Million to Draw On, An Iconoclast Invents Rational Care for a Gigantic System

January 4, 2013

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001

AIDS Commission Asks, “Give Us A Chance”

September 18, 1987

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011